Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|October 7, 2024
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical studyElena Lucarini, Laura Benvenuti, Clelia Di Salvo, et al.
Frontiers in Pharmacology|December 18, 2018
Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for PreventionRocchina Colucci, Carolina Pellegrini, Matteo Fornai, et al.
International Journal of Obesity (2005)|August 8, 2018
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesityLuca Antonioli, Valentina Caputi, Matteo Fornai, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2007
Inhibition of adenosine deaminase attenuates inflammation in experimental colitisLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.
Inflammatory Bowel Diseases|June 12, 2024
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot StudyLorenzo Bertani, Luca Antonioli, Marco Fornili, et al.
Plos One|April 12, 2018
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesityDaniela Gentile, Matteo Fornai, Rocchina Colucci, et al.
Chemmedchem|July 29, 2011
Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motilityBarbara Cosimelli, Sabrina Taliani, Giovanni Greco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
Journal of Medicinal Chemistry|April 15, 2017
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel DiseaseMattia Cocco, Carolina Pellegrini, Helios Martínez-Banaclocha, et al.
European Journal of Neurology|October 20, 2022
Intestinal histomorphological and molecular alterations in patients with Parkinson's diseaseGabriele Bellini, Laura Benvenuti, Chiara Ippolito, et al.
Pageof 13